Investing35m
AbbVie shares slip after schizophrenia drug trial misses primary endpoint
In October, AbbVie lifted his full-year income forecast, saying its was seeing "momentum" in its operations after ...
Investing46m
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza ...